Aisling Burnand CBE, 1964-2022
It is with deep sadness that we share the news that our trustee, colleague and friend, Aisling…
We were disappointed to see the lack of progress on the UK's involvement in Horizon Europe at last week's talks. We… https://t.co/gdJfNihPhS
Her Majesty Queen Elizabeth II
We at LifeArc are deeply saddened by the passing of our monarch, Her Majesty Queen Elizabeth II.…
Seven questions about LifeArc’s 2030 ambitions
Melanie Lee talks about LifeArc’s commitment to patients, and explains why we should all care about science translation.
LifeArc helps create new MRC spin-out company
Our technology transfer team played a crucial role in the formation of Constructive Bio, a new Medical…
Driving translational research into childhood rare diseases
Four grants awarded to projects that aim to translate research discoveries into benefits for children affected by rare diseases
Advancing novel gene therapies into the clinic
Report on progress to establish Innovation Hubs for Gene Therapies to advance promising research into life-changing new medicines.
Study reveals potential new way to treat colorectal cancer
Scientists discovered an IL-17B receptor antibody could be used to treat colorectal cancer.
Startup wins first Advise & Connect Innovation Award
iLOF is a startup that has a novel technology with the potential to transform personalised medicine.
Milner Therapeutics Institute and LifeArc extend strategic partnership
Combines LifeArc’s translational expertise with the Milner’s cutting-edge bioinformatics